A new study published in The Spine Journal examines long-term data on the risk for cancer associated with recombinant human bone morphogenetic protein use in spinal fusions. By Laura Dyrda - 5/20/19

A new study published in Spine examines 30- and 90-day readmission rates for spinal fusions. By Laura Dyrda - 5/17/19

Clinical stage regenerative medicine company, SpinalCyte, now features research studies on its website outlining the potential benefits of fibroblast technology. By Alan Condon - 5/15/19

Fort Collins, Colo.-based bioavailable cannabis solutions company, Geocann, hired Anthony Petraglia, MD, as CMO, and chairman of the Scientific and Medical Advisory Board. By Alan Condon - 5/15/19

Five spine surgeons discuss where they expect technology to evolve over the next half-decade. By Laura Dyrda - 5/15/19

A new study published in Spine examines bone graft substitutes for one- and two-level anterior cervical discectomy and fusion. By Laura Dyrda - 5/13/19

Vail, Colo.-based Steadman Clinic's Matthew Provencher, MD, received AlloSource's Dr. Steven Gitelis Inspiration Award to recognize his work using donated human tissue to help patients heal. By Eric Oliver - 5/9/19

Marietta, Ga.-based biopharmaceutical company MiMedx has appointed Timothy Wright as its new CEO. By Alan Condon - 5/9/19

Orthopedic surgeon at San Diego-based Grossmont Hospital Scott A. Hacker, MD, treated the first four patients in the west coast with medical device company CartiHeal's Agili-C cartilage regeneration implant. By Alan Condon - 5/7/19

San Antonio-based nonprofit BioBridge Global has added orthopedic surgeon Michael J. Yaszemski, MD, PhD, to its regenerative medicine advisory board. By Alan Condon - 5/7/19

New York-based medical device manufacturer Misonix agreed to acquire privately held wound-healing company Solys Medical of Newport News, Va., in an all-stock transaction valued at $97 million. By Alan Condon - 5/6/19

Biomedical engineers and researchers from North Carolina State University, N.C., have partnered with University of North Carolina, N.C., scientists to create new body tissues using a patient's own cells, which may help more patients avoid knee replacement surgery, reports WRAL, a local NBC affiliate in North Carolina. By Alan Condon - 4/29/19

A Montana therapeutic drug developer and California biotech company have agreed to collaborate on novel approaches for treating disorders of the central nervous system. By Alan Condon - 4/25/19

Stem cell treatments are experimental in orthopedics, but their use is promising, according to Jeffrey Carroll, MD. By Laura Dyrda - 4/23/19

A new study published in Spine examines hospital resource utilization for spine surgery patients who need treatment for Staphylococcus aureus infection with 180 days of surgery. By Laura Dyrda - 4/22/19

A new study from Market Research Gazette examines the spinal fusion market. By Laura Dyrda - 4/22/19

Altrua HealthShare and Regenexx partnered to offer Altrua members access to Regenexx's regenerative medicine treatments. By Eric Oliver - 4/19/19

UC San Francisco department of orthopedic surgery researcher Annarita Scaramozza, PhD, has made a discovery that could boost recovery from radiation therapy for cancer treatment with 'super hero' stem cells. By Laura Dyrda - 4/19/19

A new study published in Spine compares open and Wiltse minimally invasive transforaminal lumbar interbody fusion outcomes.  By Laura Dyrda - 4/18/19

The interbody fusion cage market is expected to grow through 2025, according to a MarketReserachNest report. By Laura Dyrda - 4/18/19